Dutch registry reports one-year outcomes for percutaneous deep vein arterialization

This prospective multicenter Dutch registry followed 23 patients (26 limbs) with chronic limb-threatening ischemia and no standard revascularization options who underwent percutaneous deep venous arterialization (pDVA) using the LimFlow system. The registry reported 100% technical success, 69.2% amputation-free survival, 80.8% limb salvage, and 88.5% overall survival at 12 months, though primary patency was low (6.6%) and reinterventions were frequent. The authors state pain scores and quality of life improved over the year, but note these findings warrant confirmation in larger studies.

Most relevant for: Patients with chronic limb-threatening ischemia who have no standard surgical or endovascular revascularization options.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.